145 related articles for article (PubMed ID: 25494608)
1. A new low-frequency alloantigen (Kha(b) ) located on platelet glycoprotein IIIa as a cause of maternal sensitization leading to neonatal alloimmune thrombocytopenia.
Sullivan MJ; Peterson J; McFarland JG; Bougie D; Aster RH; Curtis BR
Transfusion; 2015 Jun; 55(6 Pt 2):1584-5. PubMed ID: 25494608
[No Abstract] [Full Text] [Related]
2. Severe neonatal alloimmune thrombocytopenia caused by maternal sensitization against a new low-frequency alloantigen (Dom
Sullivan MJ; Kuhlmann R; Peterson JA; Curtis BR
Transfusion; 2017 Jul; 57(7):1847-1848. PubMed ID: 28518345
[No Abstract] [Full Text] [Related]
3. Neonatal alloimmune thrombocytopenia due to a new alloantigen Bl(a) defined by an Asp458Gly substitution in GPIIIa.
Poles A; Lucas G; Green F; Walser P; Davey S; Ridgwell K; Wylie P
Transfusion; 2019 Jan; 59(1):396-404. PubMed ID: 30488955
[TBL] [Abstract][Full Text] [Related]
4. New low-frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia.
Peterson JA; Gitter ML; Kanack A; Curtis B; McFarland J; Bougie D; Aster R
Transfusion; 2010 Feb; 50(2):324-33. PubMed ID: 19821948
[TBL] [Abstract][Full Text] [Related]
5. Three novel beta3 domain-deletion peptides for the sensitive and specific detection of HPA-4 and six low frequency beta3-HPA antibodies.
Stafford P; Garner SF; Huiskes E; Kaplan C; Kekomaki R; Santoso S; Tsuno NH; Watkins NA; Ouwehand WH
J Thromb Haemost; 2008 Feb; 6(2):376-83. PubMed ID: 18031296
[TBL] [Abstract][Full Text] [Related]
6. A new platelet alloantigen (Efs
Bertrand G; Danger Y; Croisille L; Le Toriellec E; Verite F; Renac V; Bierling P
Transfusion; 2019 Jul; 59(7):2463-2464. PubMed ID: 30942487
[No Abstract] [Full Text] [Related]
7. The αIIb p.Leu841Met (Cab3(a+) ) polymorphism results in a new human platelet alloantigen involved in neonatal alloimmune thrombocytopenia.
Jallu V; Bertrand G; Bianchi F; Chenet C; Poulain P; Kaplan C
Transfusion; 2013 Mar; 53(3):554-63. PubMed ID: 22738334
[TBL] [Abstract][Full Text] [Related]
8. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
[TBL] [Abstract][Full Text] [Related]
9. A V740L mutation in glycoprotein IIb defines a novel epitope (War) associated with fetomaternal alloimmune thrombocytopenia.
Poles A; Woźniak MJ; Walser P; Ridgwell K; Fitzgerald J; Green A; Gilmore R; Lucas G
Transfusion; 2013 Sep; 53(9):1965-73. PubMed ID: 23305224
[TBL] [Abstract][Full Text] [Related]
10. Immunologic and structural analysis of eight novel domain-deletion beta3 integrin peptides designed for detection of HPA-1 antibodies.
Stafford P; Ghevaert C; Campbell K; Proulx C; Smith G; Williamson LM; Ranasinghe E; Watkins NA; Huntington JA; Ouwehand WH
J Thromb Haemost; 2008 Feb; 6(2):366-75. PubMed ID: 18045240
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes.
Zhang N; Zhi H; Curtis BR; Rao S; Jobaliya C; Poncz M; French DL; Newman PJ
Blood; 2016 Feb; 127(6):675-80. PubMed ID: 26634302
[TBL] [Abstract][Full Text] [Related]
12. New developments in fetal and neonatal alloimmune thrombocytopenia.
Bussel JB; Vander Haar EL; Berkowitz RL
Am J Obstet Gynecol; 2021 Aug; 225(2):120-127. PubMed ID: 33839095
[TBL] [Abstract][Full Text] [Related]
13. A point mutation c.473A > G of ITGB3 is responsible for the formation of the Wo
Holzwarth ST; Strobel J; Cooper N; Leyh J; Bayat B; Bein G; Zingsem J; Sachs UJ
Transfusion; 2020 Jan; 60(1):E5-E6. PubMed ID: 31859394
[No Abstract] [Full Text] [Related]
14. The first two cases of neonatal alloimmune thrombocytopenia associated with the low-frequency platelet antigen HPA-21bw (Nos) in Japan.
Koh Y; Ishii H; Amakishi E; Hayashi T; Matsuyama N; Fukumori Y; Hirayama F; Shimizu J; Nakauchi S; Kawa K
Transfusion; 2012 Jul; 52(7):1468-75. PubMed ID: 22211425
[TBL] [Abstract][Full Text] [Related]
15. Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia.
Salomon O; Rosenberg N
Br J Haematol; 2013 Aug; 162(3):304-12. PubMed ID: 23672281
[TBL] [Abstract][Full Text] [Related]
16. Alloantibody against new platelet alloantigen (Lap(a)) on glycoprotein IIb is responsible for a case of fetal and neonatal alloimmune thrombocytopenia.
Wihadmadyatami H; Heidinger K; Röder L; Werth S; Giptner A; Hackstein H; Knorr M; Bein G; Sachs UJ; Santoso S
Transfusion; 2015 Dec; 55(12):2920-9. PubMed ID: 26388194
[TBL] [Abstract][Full Text] [Related]
17. A case of neonatal thrombocytopenia caused by maternal alloimmunization against a new platelet antigen (Bzh
Bertrand G; Danger Y; Laurichesse M; Verite F; Renac V
Transfusion; 2019 Apr; 59(4):1402-1403. PubMed ID: 30586473
[No Abstract] [Full Text] [Related]
18. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.
Yougbaré I; Lang S; Yang H; Chen P; Zhao X; Tai WS; Zdravic D; Vadasz B; Li C; Piran S; Marshall A; Zhu G; Tiller H; Killie MK; Boyd S; Leong-Poi H; Wen XY; Skogen B; Adamson SL; Freedman J; Ni H
J Clin Invest; 2015 Apr; 125(4):1545-56. PubMed ID: 25774504
[TBL] [Abstract][Full Text] [Related]
19. Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max a) is an important cause of neonatal alloimmune thrombocytopenia.
Peterson JA; Balthazor SM; Curtis BR; McFarland JG; Aster RH
Transfusion; 2005 Sep; 45(9):1487-95. PubMed ID: 16131382
[TBL] [Abstract][Full Text] [Related]
20. A new platelet alloantigen, Swi(a) , located on glycoprotein Ia identified in a family with fetal and neonatal alloimmune thrombocytopenia.
Kroll H; Feldmann K; Zwingel C; Hoch J; Bald R; Bein G; Bayat B; Santoso S
Transfusion; 2011 Aug; 51(8):1745-54. PubMed ID: 21332723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
